PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 134 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $26,000 | -70.1% | 13,419 | -30.4% | 0.00% | – |
| Q4 2021 | $87,000 | -43.5% | 19,274 | -39.3% | 0.00% | -100.0% |
| Q3 2021 | $154,000 | +27.3% | 31,745 | +37.2% | 0.00% | 0.0% |
| Q2 2020 | $121,000 | -1.6% | 23,146 | +371.6% | 0.00% | 0.0% |
| Q3 2017 | $123,000 | -8.9% | 4,908 | -43.8% | 0.00% | 0.0% |
| Q4 2016 | $135,000 | +25.0% | 8,737 | +54.0% | 0.00% | 0.0% |
| Q3 2015 | $108,000 | -91.2% | 5,674 | -82.2% | 0.00% | -83.3% |
| Q4 2014 | $1,226,000 | – | 31,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |